IL1B and diabetes mellitus: Among the complex network of pro-inflammatory cytokines that are related to chronic metabolic diseases, interleukin (IL)-1β has been recognized to be an important player in initiating and sustaining inflammation-induced organ dysfunction in DM [8,9,10].